Edition:
United States

People: Alere Inc (ALR_pb.N)

ALR_pb.N on New York Stock Exchange

326.00USD
20 Jan 2017
Change (% chg)

$-1.50 (-0.46%)
Prev Close
$327.50
Open
$328.17
Day's High
$328.17
Day's Low
$326.00
Volume
480
Avg. Vol
735
52-wk High
$406.88
52-wk Low
$255.75

Bridgen, John 

Dr. John Bridgen, Ph.D., serves as Senior Vice President - Business Development of Alere Inc. He has served as Senior Vice President, Business Development since July 2010, after serving as our Vice President, Business Development from June 2006 to July 2010. He served as our Vice President, Strategy from September 2005 to June 2006. Dr. Bridgen joined our Company in September 2002, upon our acquisition of Wampole Laboratories, LLC. Dr. Bridgen served as President of Wampole from August 1984 until September 2005. Prior to joining Wampole, Dr. Bridgen had global sales and marketing responsibility for the hematology and immunology business units of Ortho Diagnostic Systems Inc., a Johnson & Johnson company.

Basic Compensation

Total Annual Compensation, USD 553,600
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 332,985
Fiscal Year Total, USD 886,585

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gregg Powers

85,000

Namal Nawana

11,143,600

James Hinrichs

8,931,760

Daniella Cramp

1,509,440

Sanjay Malkani

1,624,140

Avi Pelossof

1,607,070
As Of  30 Dec 2015